LRP1 protects against excessive superior mesenteric artery remodeling by modulating angiotensin II-mediated signaling

JCI Insight. 2023 Jan 24;8(2):e164751. doi: 10.1172/jci.insight.164751.

Abstract

Vascular smooth muscle cells (vSMCs) exert a critical role in sensing and maintaining vascular integrity. These cells abundantly express the low-density lipoprotein receptor-related protein 1 (LRP1), a large endocytic signaling receptor that recognizes numerous ligands, including apolipoprotein E-rich lipoproteins, proteases, and protease-inhibitor complexes. We observed the spontaneous formation of aneurysms in the superior mesenteric artery (SMA) of both male and female mice in which LRP1 was genetically deleted in vSMCs (smLRP1-/- mice). Quantitative proteomics revealed elevated abundance of several proteins in smLRP1-/- mice that are known to be induced by angiotensin II-mediated (AngII-mediated) signaling, suggesting that this pathway was dysregulated. Administration of losartan, an AngII type I receptor antagonist, or an angiotensinogen antisense oligonucleotide to reduce plasma angiotensinogen concentrations restored the normal SMA phenotype in smLRP1-/- mice and prevented aneurysm formation. Additionally, using a vascular injury model, we noted excessive vascular remodeling and neointima formation in smLRP1-/- mice that was restored by losartan administration. Together, these findings reveal that LRP1 regulates vascular integrity and remodeling of the SMA by attenuating excessive AngII-mediated signaling.

Keywords: Cardiovascular disease; Vascular Biology.

MeSH terms

  • Angiotensin II*
  • Angiotensinogen
  • Animals
  • Female
  • Losartan
  • Low Density Lipoprotein Receptor-Related Protein-1 / metabolism
  • Male
  • Mesenteric Artery, Superior* / metabolism
  • Mice
  • Signal Transduction

Substances

  • Angiotensin II
  • Angiotensinogen
  • Losartan
  • Lrp1 protein, mouse
  • Low Density Lipoprotein Receptor-Related Protein-1